Acutely Induced Insulin Resistance by Antipsychotic Medication in Healthy Volunteers: Impact of Skeletal Muscle Epigenomic and Proteomic Mechanisms

健康志愿者抗精神病药物急性诱导胰岛素抵抗:骨骼肌表观基因组和蛋白质组机制的影响

基本信息

  • 批准号:
    9750240
  • 负责人:
  • 金额:
    $ 16.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-01 至 2022-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT This K23 Patient-Oriented Mentored Research Award builds on the candidate’s expertise in pharmacology and epigenetics to provide the support necessary to complete training in responsible conduct of research and three other needs: 1) clinical research design and execution, 2) in vivo insulin sensitivity measurement, 3) design and execution proteomics experiments. This training will be accomplished through a combination of expert mentor- ship, didactic (short courses and certificate program) and hands-on experiences (human insulin sensitivity meas- urements and proteomics). The career development activities and research will be mentored by Dr. Zhengping Yi (Primary) and Dr. Renu Kowluru, and supplemented by a physician key collaborator (Dr. Berhane Seyoum), consultants and a yearly, external scientific advisory committee. The candidate’s transition to independence will be aided by an R01 grant writing program, presentation of findings at national conferences and publication of results in high-impact journals. The research plan will provide a platform for training and address a gap in the understanding of how atypical antipsychotics cause insulin resistance. The long-term goal of the proposed work is to establish and sustain an independent career focused on the impact of molecular factors and mechanisms in medication outcomes. The objective is to determine the causal relationship between the observed skeletal muscle epigenetic and protein changes in response to atypical antipsychotics, and the development of insulin resistance using a randomized, placebo-controlled, 7-day trial of olanzapine in healthy volunteers. The central hypothesis, based on preliminary data, is that obesity- and mental illness-independent atypical antipsychotic- induced insulin resistance is caused by DNA hypermethylation and altered protein abundance and regulation in the skeletal muscle. The rationale for this work is that it will establish the molecular mechanisms that underlie atypical antipsychotic-induced insulin resistance, while providing the training and expertise for a research pro- gram to develop precise, tractable targets for future interventions to alleviate epigenetic and/or protein-based dysregulations. The central hypothesis will be tested by obtaining baseline and endpoint basal and insulin-stim- ulated skeletal muscle samples from the 7-day trial in the following specific aims: 1) Identify the relevant genes affected by the hypermethylation seen with atypical antipsychotic-induced insulin resistance and 2) Determine the relevant protein changes underlying obesity-independent atypical antipsychotic-induced insulin resistance. The approach is innovative, in the candidate’s opinion, because it seeks to change the status quo of assessing molecular changes in psychiatric populations already using antipsychotics and because it seeks to assess these changes in a tissue-specific manner using powerful epigenomic and proteomic approaches. The proposed work is significant because it is expected to have a positive impact both on the field, and in positioning the candidate for independence. This work will provide the basis for targeting the molecular dysregulations caused by antipsy- chotics and preventing mortality from insulin resistance and diabetes.
项目概要/摘要 K23 以患者为中心的指导研究奖建立在候选人在药理学和 表观遗传学提供必要的支持来完成负责任的研究行为的培训和三个 其他需求:1)临床研究设计和执行,2)体内胰岛素敏感性测量,3)设计和 执行蛋白质组学实验将通过专家导师的结合来完成。 船舶、教学(短期课程和证书课程)和实践经验(人类胰岛素敏感性测量) 职业发展活动和研究将由郑平博士指导。 Yi(小学)和 Renu Kowluru 博士,并辅以一位医师主要合作者(Berhane Seyoum 博士), 顾问和每年一次的外部科学咨询委员会将帮助候选人向独立过渡。 得到 R01 资助写作计划、在全国会议上展示研究结果以及出版 该研究计划将为培训提供一个平台,并解决该领域的空白。 了解非典型抗精神病药物如何导致胰岛素抵抗 拟议工作的长期目标。 是建立并维持专注于分子因素和机制影响的独立职业 目的是确定观察到的骨骼之间的因果关系。 非典型抗精神病药引起的肌肉表观遗传和蛋白质变化以及胰岛素的发展 使用奥氮平在健康志愿者中进行的随机、安慰剂对照、为期 7 天的试验来确定耐药性。 基于初步数据的假设是,与肥胖和精神疾病无关的非典型抗精神病药物 诱导的胰岛素抵抗是由 DNA 高甲基化和蛋白质丰度和调节引起的 这项工作的基本原理是它将建立骨骼肌的分子机制。 非典型抗精神病药物引起的胰岛素抵抗,同时为研究人员提供培训和专业知识 克为未来的干预措施制定精确、易于处理的目标,以减轻表观遗传和/或基于蛋白质的影响 中心假设将通过获得基线和终点基础和胰岛素刺激来检验。 从 7 天的试验中提取骨骼肌样本,其具体目标如下:1) 识别相关基因 受非典型抗精神病药物引起的胰岛素抵抗所见的高甲基化的影响,并且 2) 确定 与肥胖无关的非典型抗精神病药物引起的胰岛素抵抗的相关蛋白质变化。 候选人认为,这种方法是创新的,因为它试图改变评估的现状 已经使用抗精神病药物的精神病人群的分子变化,因为它试图评估这些变化 使用强大的表观基因组和蛋白质组方法以组织特异性方式发生变化。 意义重大,因为预计它将对该领域以及候选人的定位产生积极影响 这项工作将为针对反解剖引起的分子失调提供基础。 胆汁酸并预防胰岛素抵抗和糖尿病造成的死亡。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kyle Jon Burghardt其他文献

Kyle Jon Burghardt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kyle Jon Burghardt', 18)}}的其他基金

Acutely Induced Insulin Resistance by Antipsychotic Medication in Healthy Volunteers: Impact of Skeletal Muscle Epigenomic and Proteomic Mechanisms
健康志愿者抗精神病药物急性诱导胰岛素抵抗:骨骼肌表观基因组和蛋白质组机制的影响
  • 批准号:
    10220957
  • 财政年份:
    2018
  • 资助金额:
    $ 16.84万
  • 项目类别:
Acutely Induced Insulin Resistance by Antipsychotic Medication in Healthy Volunteers: Impact of Skeletal Muscle Epigenomic and Proteomic Mechanisms
健康志愿者抗精神病药物急性诱导胰岛素抵抗:骨骼肌表观基因组和蛋白质组机制的影响
  • 批准号:
    10220245
  • 财政年份:
    2018
  • 资助金额:
    $ 16.84万
  • 项目类别:
Acutely Induced Insulin Resistance by Antipsychotic Medication in Healthy Volunteers: Impact of Skeletal Muscle Epigenomic and Proteomic Mechanisms
健康志愿者抗精神病药物急性诱导胰岛素抵抗:骨骼肌表观基因组和蛋白质组机制的影响
  • 批准号:
    9978821
  • 财政年份:
    2018
  • 资助金额:
    $ 16.84万
  • 项目类别:

相似国自然基金

巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
  • 批准号:
    82304503
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
  • 批准号:
    82374256
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
  • 批准号:
    82300771
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
  • 批准号:
    82374209
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Phosphatidylinositol 3-Phosphate in the Regulation of Autophagic Membrane Remodeling
磷脂酰肌醇 3-磷酸在自噬膜重塑调节中的作用
  • 批准号:
    10506784
  • 财政年份:
    2022
  • 资助金额:
    $ 16.84万
  • 项目类别:
Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
PI3K 抑制预防 B 细胞急性淋巴细胞白血病复发的新用途
  • 批准号:
    10455633
  • 财政年份:
    2021
  • 资助金额:
    $ 16.84万
  • 项目类别:
Novel use of PI3K inhibition to prevent recurrence of B-cell acute lymphoblastic leukemia
PI3K 抑制预防 B 细胞急性淋巴细胞白血病复发的新用途
  • 批准号:
    10289183
  • 财政年份:
    2021
  • 资助金额:
    $ 16.84万
  • 项目类别:
Neuropilin-2 in Alloimmunity
同种免疫中的 Neuropilin-2
  • 批准号:
    10355442
  • 财政年份:
    2020
  • 资助金额:
    $ 16.84万
  • 项目类别:
The Na/K-ATPase receptor function as a novel therapeutic target in myocardial infarction
Na/K-ATP酶受体作为心肌梗死的新型治疗靶点
  • 批准号:
    9813314
  • 财政年份:
    2019
  • 资助金额:
    $ 16.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了